Skip to content

InMed Pharmaceuticals Inc.

INM · XNAS

CIK 1728328fmd_1A47FQ1QX1QZADESTC9WQJHZ3PManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2019 to Sep 30, 2026, 29 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading
FinancialMD terminal